Does IBRUTINIB Cause Non-small cell lung cancer? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Non-small cell lung cancer have been filed in association with IBRUTINIB (Imbruvica). This represents 0.1% of all adverse event reports for IBRUTINIB.
34
Reports of Non-small cell lung cancer with IBRUTINIB
0.1%
of all IBRUTINIB reports
3
Deaths
3
Hospitalizations
How Dangerous Is Non-small cell lung cancer From IBRUTINIB?
Of the 34 reports, 3 (8.8%) resulted in death, 3 (8.8%) required hospitalization.
Is Non-small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
CRIZOTINIB (178)
AMG-510 (134)
Which IBRUTINIB Alternatives Have Lower Non-small cell lung cancer Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE